| Wissenschaftl. Titel | A Phase III, Multicenter, Randomized, Parallel Group, Double Blind, Double Dummy, Active Controlled Study of Evobrutinib Compared with Teriflunomide, in Participants with Relapsing Multiple Sclerosis to Evaluate Efficacy and Safety |
| Erkrankung |
Nervensystem:
Multiple Sklerose
|
| weitere Prüfzentren | |
| Kurzprotokoll | Kurzprotokoll |
erstellt 19.07.2021 Student Studienregister
geändert 11.07.2023 Admin02